The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Trazodone Hydrochloride (API) Market Research Report 2024
Synopsis
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
This report covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
The global Trazodone Hydrochloride (API) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Trazodone hydrochloride (API) consumed in USA are mostly imported from overseas. Major companies are Angelini, Mylan, SST Corporation, The Piramal Group. The sales market share of the four companies has reached 53%. The local factory, Teva occupied about 40% market share.
This report aims to provide a comprehensive presentation of the global market for Trazodone Hydrochloride (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trazodone Hydrochloride (API).
Report Scope
The Trazodone Hydrochloride (API) market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Trazodone Hydrochloride (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Trazodone Hydrochloride (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Angelini
Mylan
Fermion
The Piramal Group
Segment by Type
Trazodone Hydrochloride (API)
Others
Segment by Application
Antidepression
Anxiolytic
Hypnotic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Trazodone Hydrochloride (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Trazodone Hydrochloride (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
This report covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
The global Trazodone Hydrochloride (API) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Trazodone hydrochloride (API) consumed in USA are mostly imported from overseas. Major companies are Angelini, Mylan, SST Corporation, The Piramal Group. The sales market share of the four companies has reached 53%. The local factory, Teva occupied about 40% market share.
This report aims to provide a comprehensive presentation of the global market for Trazodone Hydrochloride (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trazodone Hydrochloride (API).
Report Scope
The Trazodone Hydrochloride (API) market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Trazodone Hydrochloride (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Trazodone Hydrochloride (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Angelini
Mylan
Fermion
The Piramal Group
Segment by Type
Trazodone Hydrochloride (API)
Others
Segment by Application
Antidepression
Anxiolytic
Hypnotic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Trazodone Hydrochloride (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Trazodone Hydrochloride (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Trazodone Hydrochloride (API) Market Overview
1.1 Product Overview and Scope of Trazodone Hydrochloride (API)
1.2 Trazodone Hydrochloride (API) Segment by Type
1.2.1 Global Trazodone Hydrochloride (API) Market Value Comparison by Type (2024-2030)
1.2.2 Trazodone Hydrochloride (API)
1.2.3 Others
1.3 Trazodone Hydrochloride (API) Segment by Application
1.3.1 Global Trazodone Hydrochloride (API) Market Value by Application: (2024-2030)
1.3.2 Antidepression
1.3.3 Anxiolytic
1.3.4 Hypnotic
1.3.5 Others
1.4 Global Trazodone Hydrochloride (API) Market Size Estimates and Forecasts
1.4.1 Global Trazodone Hydrochloride (API) Revenue 2019-2030
1.4.2 Global Trazodone Hydrochloride (API) Sales 2019-2030
1.4.3 Global Trazodone Hydrochloride (API) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Trazodone Hydrochloride (API) Market Competition by Manufacturers
2.1 Global Trazodone Hydrochloride (API) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Trazodone Hydrochloride (API) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Trazodone Hydrochloride (API) Average Price by Manufacturers (2019-2024)
2.4 Global Trazodone Hydrochloride (API) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Trazodone Hydrochloride (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Trazodone Hydrochloride (API), Product Type & Application
2.7 Trazodone Hydrochloride (API) Market Competitive Situation and Trends
2.7.1 Trazodone Hydrochloride (API) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Trazodone Hydrochloride (API) Players Market Share by Revenue
2.7.3 Global Trazodone Hydrochloride (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Trazodone Hydrochloride (API) Retrospective Market Scenario by Region
3.1 Global Trazodone Hydrochloride (API) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Trazodone Hydrochloride (API) Global Trazodone Hydrochloride (API) Sales by Region: 2019-2030
3.2.1 Global Trazodone Hydrochloride (API) Sales by Region: 2019-2024
3.2.2 Global Trazodone Hydrochloride (API) Sales by Region: 2025-2030
3.3 Global Trazodone Hydrochloride (API) Global Trazodone Hydrochloride (API) Revenue by Region: 2019-2030
3.3.1 Global Trazodone Hydrochloride (API) Revenue by Region: 2019-2024
3.3.2 Global Trazodone Hydrochloride (API) Revenue by Region: 2025-2030
3.4 North America Trazodone Hydrochloride (API) Market Facts & Figures by Country
3.4.1 North America Trazodone Hydrochloride (API) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Trazodone Hydrochloride (API) Sales by Country (2019-2030)
3.4.3 North America Trazodone Hydrochloride (API) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Trazodone Hydrochloride (API) Market Facts & Figures by Country
3.5.1 Europe Trazodone Hydrochloride (API) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Trazodone Hydrochloride (API) Sales by Country (2019-2030)
3.5.3 Europe Trazodone Hydrochloride (API) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Trazodone Hydrochloride (API) Market Facts & Figures by Country
3.6.1 Asia Pacific Trazodone Hydrochloride (API) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Trazodone Hydrochloride (API) Sales by Country (2019-2030)
3.6.3 Asia Pacific Trazodone Hydrochloride (API) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Trazodone Hydrochloride (API) Market Facts & Figures by Country
3.7.1 Latin America Trazodone Hydrochloride (API) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Trazodone Hydrochloride (API) Sales by Country (2019-2030)
3.7.3 Latin America Trazodone Hydrochloride (API) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Trazodone Hydrochloride (API) Market Facts & Figures by Country
3.8.1 Middle East and Africa Trazodone Hydrochloride (API) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Trazodone Hydrochloride (API) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Trazodone Hydrochloride (API) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Trazodone Hydrochloride (API) Sales by Type (2019-2030)
4.1.1 Global Trazodone Hydrochloride (API) Sales by Type (2019-2024)
4.1.2 Global Trazodone Hydrochloride (API) Sales by Type (2025-2030)
4.1.3 Global Trazodone Hydrochloride (API) Sales Market Share by Type (2019-2030)
4.2 Global Trazodone Hydrochloride (API) Revenue by Type (2019-2030)
4.2.1 Global Trazodone Hydrochloride (API) Revenue by Type (2019-2024)
4.2.2 Global Trazodone Hydrochloride (API) Revenue by Type (2025-2030)
4.2.3 Global Trazodone Hydrochloride (API) Revenue Market Share by Type (2019-2030)
4.3 Global Trazodone Hydrochloride (API) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Trazodone Hydrochloride (API) Sales by Application (2019-2030)
5.1.1 Global Trazodone Hydrochloride (API) Sales by Application (2019-2024)
5.1.2 Global Trazodone Hydrochloride (API) Sales by Application (2025-2030)
5.1.3 Global Trazodone Hydrochloride (API) Sales Market Share by Application (2019-2030)
5.2 Global Trazodone Hydrochloride (API) Revenue by Application (2019-2030)
5.2.1 Global Trazodone Hydrochloride (API) Revenue by Application (2019-2024)
5.2.2 Global Trazodone Hydrochloride (API) Revenue by Application (2025-2030)
5.2.3 Global Trazodone Hydrochloride (API) Revenue Market Share by Application (2019-2030)
5.3 Global Trazodone Hydrochloride (API) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Trazodone Hydrochloride (API) Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Angelini
6.2.1 Angelini Corporation Information
6.2.2 Angelini Description and Business Overview
6.2.3 Angelini Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Angelini Trazodone Hydrochloride (API) Product Portfolio
6.2.5 Angelini Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Trazodone Hydrochloride (API) Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Fermion
6.4.1 Fermion Corporation Information
6.4.2 Fermion Description and Business Overview
6.4.3 Fermion Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fermion Trazodone Hydrochloride (API) Product Portfolio
6.4.5 Fermion Recent Developments/Updates
6.5 The Piramal Group
6.5.1 The Piramal Group Corporation Information
6.5.2 The Piramal Group Description and Business Overview
6.5.3 The Piramal Group Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 The Piramal Group Trazodone Hydrochloride (API) Product Portfolio
6.5.5 The Piramal Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Trazodone Hydrochloride (API) Industry Chain Analysis
7.2 Trazodone Hydrochloride (API) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Trazodone Hydrochloride (API) Production Mode & Process
7.4 Trazodone Hydrochloride (API) Sales and Marketing
7.4.1 Trazodone Hydrochloride (API) Sales Channels
7.4.2 Trazodone Hydrochloride (API) Distributors
7.5 Trazodone Hydrochloride (API) Customers
8 Trazodone Hydrochloride (API) Market Dynamics
8.1 Trazodone Hydrochloride (API) Industry Trends
8.2 Trazodone Hydrochloride (API) Market Drivers
8.3 Trazodone Hydrochloride (API) Market Challenges
8.4 Trazodone Hydrochloride (API) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
